The widower of a New Jersey woman who died suddenly while using the NuvaRing contraceptive has filed suit against its maker, claiming the device caused a deadly blood clot. It was alleged that Nuvaring, which the 32-year-old mother of two had been using for six months, contributed to her death. Defendants in the case are Organon BioSciences NV and Schering-Plough Corp., which bought the Dutch biopharmaceutical company in November.
NuvaRing, which was launched in the summer of 2002, is a hormonal contraceptive inside a flexible ring that is inserted in the vagina and left in place for three weeks out of every month. It slowly releases two hormones into the vaginal wall: ethinyl estradiol, a type of estrogen widely used in contraceptives, and a progestin called etonogestrel. Etonogestrel is the active form of a contraceptive hormone called desogestrol contained in several newer birth-control pills, including Mircette, Desogen and Ortho-Cept. Public Citizen Health Research Group has been pushing the Food and Drug Administration since February 2007 to remove those pills from the market because they double the risk of blood clots without having any benefit over other contraceptives, according to the group’s director, Dr. Sidney Wolfe.
Source: Associated Press
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.